This post has been archived and contains information that may be out of date.
What’s happening: CHA submitted comments in response to the Board of Pharmacy (BoP) proposed regulations on nonsterile compounding, sterile compounding, and hazardous medications. What else to know: In these comments, CHA raises concerns about the regulations’ benefit to patients, the significant financial impact to hospitals, and the lack of evidence that pharmacies are not complying...
This content is restricted to members.
